AAAAAA
Results:
1-15
|
Results: 15
Authors:
MADAI A
HOLTL W
Citation: A. Madai et W. Holtl, PUBLICATIONS - GOOD OR BAD - CRITICAL-APP RAISAL OF SCIENTIFIC PAPERS, Wiener Klinische Wochenschrift, 110(2), 1998, pp. 58-62
Authors:
VANDERMEIJDEN A
BRAUSI M
ZAMBON V
KIRKELS W
HOLTL W
BONO A
DEBALINCOURT C
SYLVESTER R
Citation: A. Vandermeijden et al., EORTC PROTOCOL-30911 - PHASE-III STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG TICE AND BCG TICE PLUS ISONIAZID IN INTERMEDIATE ANDHIGH-RISK PTA-PTL PAPILLARY CARCINOMA OF THE BLADDER, The Journal of urology, 159(5), 1998, pp. 554-554
Authors:
TOMSCHI W
SUSTER G
HOLTL W
Citation: W. Tomschi et al., BLADDER NECK STRICTURES AFTER RADICAL RETROPUBIC PROSTATECTOMY - STILL AN UNSOLVED PROBLEM, British Journal of Urology, 81(6), 1998, pp. 823-826
Authors:
SCHOLZ M
LUFTENEGGER W
HARMUTH H
WOLF D
HOLTL W
Citation: M. Scholz et al., SINGLE-DOSE ANTIBIOTIC-PROPHYLAXIS IN TRANSURETHRAL RESECTION OF THE PROSTATE - A PROSPECTIVE RANDOMIZED TRIAL, British Journal of Urology, 81(6), 1998, pp. 827-829
Authors:
VANDERMEIJDEN A
BRAUSI M
HOLTL W
MACK D
VANVELTHOVEN R
DASILVA FC
SYLVESTER R
DEBALINCOURT C
Citation: A. Vandermeijden et al., COMPARATIVE-STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG, ORBCG-RISK PTA-PT1 PAPILLARY CARCINOMA OF THE URINARY-BLADDER - FIRST RESULTS OF EORTC-30911(INH IN INTERMEDIATE AND HIGH), European journal of cancer, 33, 1997, pp. 615-615
Authors:
PONT J
HOLTL W
WEISSBACH L
BEYER J
SIEGERT W
Citation: J. Pont et al., HIGH-DOSE CHEMOTHERAPY AND REINFUSION OF HEMATOPOIETIC STEM-CELLS ADVANCED GERM-CELL TUMORS WITH POOR-PROGNOSIS IN 1996, Der Urologe, 36(6), 1997, pp. 561-564
Authors:
VEGT PDJ
VANDERMEIJDEN APM
SYLVESTER R
BRAUSI M
HOLTL W
DEBALINCOURT C
Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911, The Journal of urology, 157(4), 1997, pp. 1246-1249
Authors:
VEGT PDJ
VANDERMEIJDEN APM
SYLVESTER R
BRAUSI M
HOLTL W
DEBALINCOURT C
Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911 - REPLY, The Journal of urology, 157(4), 1997, pp. 1249-1249
Authors:
VOGL M
MULLER MM
HOLTL W
Citation: M. Vogl et al., PROSTATIC-CANCER - HOSPITAL-BASED PROSTATE-SPECIFIC ANTIGEN SCREENING, Clinical biochemistry, 30(4), 1997, pp. 357-360
Authors:
VOGL M
MULLER MM
HOLTL W
Citation: M. Vogl et al., CLINICAL USEFULNESS OF PERCENTAGE OF FREE SERUM PROSTATE-SPECIFIC ANTIGEN, Clinica chimica acta, 258(1), 1997, pp. 79-90
Authors:
HEIDENREICH A
HOLTL W
ALBRECHT W
PONT T
ENGELMANN UH
Citation: A. Heidenreich et al., TESTIS-PRESERVING SURGERY IN BILATERAL TESTICULAR GERM-CELL TUMORS, British Journal of Urology, 79(2), 1997, pp. 253-257
Authors:
PONT J
ALBRECHT W
POSTNER G
SELLNER F
ANGEL K
HOLTL W
Citation: J. Pont et al., ADJUVANT CHEMOTHERAPY FOR HIGH-RISK CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL CANCER - LONG-TERM RESULTS OF A PROSPECTIVE TRIAL, Journal of clinical oncology, 14(2), 1996, pp. 441-448
Authors:
HOLTL W
ALBRECHT W
Citation: W. Holtl et W. Albrecht, ELIMINATING THE NEED FOR BILATERAL PELVIC LYMPHADENECTOMY IN SELECT PATIENTS WITH, The Journal of urology, 155(1), 1996, pp. 296-296
Authors:
KOZAK W
HOLTL W
PUMMER K
MAIER U
JESCHKE K
BUCHER A
Citation: W. Kozak et al., ADRENALECTOMY - STILL A MUST IN RADICAL RENAL SURGERY, British Journal of Urology, 77(1), 1996, pp. 27-31
Authors:
FLAMM J
DONNER G
BUCHER A
HOLTL W
ALBRECHT W
HAVELEC L
Citation: J. Flamm et al., TOPICAL IMMUNOTHERAPY (KLH) VS CHEMOTHERA PY (ETOGLUCID) IN RECURRENCE PROPHYLAXIS OF SUPERFICIAL BLADDER-CARCINOMA - A PROSPECTIVE RANDOMIZED STUDY, Der Urologe, 33(2), 1994, pp. 138-143
Risultati:
1-15
|